A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 13 Feb 2015

At a glance

  • Drugs Perampanel (Primary)
  • Indications Epilepsy; Insomnia; Partial epilepsies
  • Focus Therapeutic Use
  • Sponsors Eisai Inc
  • Most Recent Events

    • 09 Feb 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
    • 16 Dec 2014 Planned End Date changed from 1 May 2016 to 1 Aug 2016, according to the ClinicalTrials.gov record.
    • 16 Dec 2014 Planned primary completion date changed from 1 Apr 2016 to 1 Aug 2016, according to the ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top